1. Home
  2. ZURA vs HBB Comparison

ZURA vs HBB Comparison

Compare ZURA & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • HBB
  • Stock Information
  • Founded
  • ZURA 2022
  • HBB 1904
  • Country
  • ZURA United States
  • HBB United States
  • Employees
  • ZURA N/A
  • HBB N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • HBB Home Furnishings
  • Sector
  • ZURA Health Care
  • HBB Consumer Discretionary
  • Exchange
  • ZURA Nasdaq
  • HBB Nasdaq
  • Market Cap
  • ZURA 69.9M
  • HBB 242.8M
  • IPO Year
  • ZURA N/A
  • HBB 2017
  • Fundamental
  • Price
  • ZURA $1.05
  • HBB $17.63
  • Analyst Decision
  • ZURA Buy
  • HBB
  • Analyst Count
  • ZURA 7
  • HBB 0
  • Target Price
  • ZURA $14.33
  • HBB N/A
  • AVG Volume (30 Days)
  • ZURA 755.8K
  • HBB 26.2K
  • Earning Date
  • ZURA 08-08-2025
  • HBB 07-30-2025
  • Dividend Yield
  • ZURA N/A
  • HBB 2.72%
  • EPS Growth
  • ZURA N/A
  • HBB 18.18
  • EPS
  • ZURA N/A
  • HBB 2.43
  • Revenue
  • ZURA N/A
  • HBB $659,788,000.00
  • Revenue This Year
  • ZURA N/A
  • HBB N/A
  • Revenue Next Year
  • ZURA N/A
  • HBB N/A
  • P/E Ratio
  • ZURA N/A
  • HBB $7.32
  • Revenue Growth
  • ZURA N/A
  • HBB 5.46
  • 52 Week Low
  • ZURA $0.97
  • HBB $13.25
  • 52 Week High
  • ZURA $5.07
  • HBB $31.78
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 48.12
  • HBB 48.06
  • Support Level
  • ZURA $1.10
  • HBB $17.32
  • Resistance Level
  • ZURA $1.22
  • HBB $18.49
  • Average True Range (ATR)
  • ZURA 0.09
  • HBB 0.82
  • MACD
  • ZURA 0.00
  • HBB -0.02
  • Stochastic Oscillator
  • ZURA 31.25
  • HBB 40.89

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

Share on Social Networks: